Динамика распространения вируса гепатита С среди потребителей инъекционных наркотиков позволяет предположить, что ежегодное лечение, превышающее 10%, устранит болезнь к 2030 году.
Summary Background and Aims In Switzerland, the prevalence of hepatitis C virus (HCV) among people who inject drugs (PWID) has been decreasing owing to active harm reduction efforts and an aging population. Recent advances in HCV therapeutics may provide an opportunity to direct treatment to high-risk populations, with a goal of reducing HCV prevalence and […]
Russian 
English 
Spanish 
French 
Arabic